Related Experiment Video
Updated: May 15, 2026

06:46
Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
Published on: February 15, 2019
Coagulation and coagulation signalling in fibrosis.
Paul F Mercer1, Rachel C Chambers
1Centre for Inflammation and Tissue Repair, University College London, Rayne Institute, 5 University St., London WC1E 6JF, UK.
Biochimica Et Biophysica Acta
|January 10, 2013
Summary
Coagulation, initially viewed as solely for blood clotting, is now recognized as crucial for wound healing. Dysregulated coagulation can lead to fibrosis in organs like the lung, liver, kidney, and heart.
Area of Science:
- Cell Biology
- Physiology
- Pathology
Background:
- Wound healing involves coagulation, inflammation, fibroproliferation, and remodeling.
- Fibrosis stems from dysregulated wound healing, characterized by excessive extracellular matrix deposition.
- Coagulation's role has expanded beyond hemostasis to orchestrating healing and pathological processes.
Purpose of the Study:
- To review the role of coagulation in tissue injury response.
- To explore coagulation-initiated signaling in wound healing and fibrosis.
- To examine coagulation's contribution to organ fibrosis.
Main Methods:
- Literature review of coagulation's role in tissue injury.
- Analysis of signaling pathways initiated by coagulation.
- Examination of evidence linking coagulation to organ-specific fibrosis.
Main Results:
- Coagulation is essential for normal wound healing, influencing inflammation and fibroproliferation.
- Sustained or uncontrolled coagulation activation drives myofibroblast proliferation and excessive matrix deposition.
- Evidence links dysregulated coagulation to fibrosis in the lung, liver, kidney, and heart.
Conclusions:
- Coagulation plays a pivotal role in both normal wound healing and the pathogenesis of organ fibrosis.
- Understanding coagulation-initiated signaling is critical for developing anti-fibrotic therapies.
- Targeting coagulation pathways may offer new strategies to treat fibrotic diseases.
More Related Videos
Related Concept Videos
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...

